News, Events & Resources
There’s a lot happening at Melinta. We are the company of the moment and enterprise of the future. Join us in realizing our vision — this is our story, and it’s going to be legendary.
Melinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development
Melinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development
October 25, 2021Press ReleaseMelinta Therapeutics Announces Appointment of Doug Girgenti as Vice President of Drug Development MORRISTOWN, N.J., Oct. 25, 2021 — Melinta Therapeutics, LLC...
Melinta Therapeutics Announces Two Key Milestones Expanding Reimbursement and Access for KIMYRSA™ (oritavancin)
Melinta Therapeutics Announces Two Key Milestones Expanding Reimbursement and Access for KIMYRSA™ (oritavancin)
KIMYRSA™ Receives Product-Specific J-Code and Transitional Pass-Through Status from CMS
Melinta Therapeutics Announces Appointment of Jisoo Park as Head of Business Development, M&A and Strategy
Melinta Therapeutics Announces Appointment of Jisoo Park as Head of Business Development, M&A and Strategy
Jisoo Park, a leader in global pharmaceutical business development, joins Melinta under the leadership of President and Chief Executive Officer Christine Ann Miller.